Alexis Brice – Director, Brain & Spine Institute (ICM), France
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Address: 26 Kallang Place #05-17 Singapore 339157,Singapore
Tel: + (65) 6299 5411
Web: http://www.icmpharma.com.sg/
ICM started in Singapore as a trading entity in 1970 under the name of Woods International Pte Ltd, which now becomes the marketing arm of veterinary products in Singapore and Malaysia. It is also their official tendering agency for pharmaceutical products to the public sector in Singapore.
There manufacturing activities started in 1975 for the range of veterinary products under Carrington brand. In the 1980s, they obtained Good Manufacturing Practice (GMP) certification from Ministry of Health (Singapore) for production of human pharmaceuticals. Thier facilities are capable of producing oral preparations, external preparations, creams and ointments.
ICM is now one of the largest local pharmaceutical manufacturers in Singapore. They have expanded into an organisation with over 60 staffs, headed by a group of professionals including pharmacists, quality control and R&D chemists, microbiologist and trained technicians
Their product range includes pharmaceuticals (both ethical and over-the-counter), cosmetics, household products and chemicals for industrial uses. They also do packing of solid dosage forms such as tablets and capsules for their clients.
Prof. Alexis Brice, director of the French Brain & Spine Institute (Institut du Cerveau et de la Moelle épinière (ICM)), reveals the recipe behind the success of the center since…
Victor Manuel Fernández Navarro, CEO at Vicma, explains how strategically important is to have a healthy business model in the distribution industry through sustainable collection period, attractive profit margins and…
To cater to Japan and Asia Pacific (JAPAC)’s booming biotech industry, in May 2021 IQVIA expanded its ‘IQVIA Biotech’ brand into the region. Looking ahead to 2022, IQVIA Biotech JAPAC…
Writing in the December edition of DIA’s Global Forum magazine, Agnes Ho, Cindy Zen, and Tan Kwee Lan of Boehringer Ingelheim give an overview of the current regulatory framework for…
Asia has experienced a biotech boom in the past five years. In 2020, almost 50 percent of the region’s clinical trials were led by biotechs and by 2025, biotech-led clinical…
Angeline Ho gives an overview of the patient advocacy landscape in Asia-Pacific, why an Asian model of patient engagement – distinct from those in Europe and the US – needs…
The Asia-Pacific (APAC) region is home to around 1.44 billion people, over 60 percent of the world’s population, and a vast diversity of cultures, infrastructures, and economic development. Managing a…
Ashish Mahajan, Partner in Deloitte’s Life Sciences and Healthcare Consulting Practice in Southeast Asia, outlines some of the key trends playing out in the region, the extent to which the…
Professor Subra Suresh, president of Nanyang Technological University (NTU) and former director of the US National Science Foundation, explains how the university has managed to consistently be among the top…
Marco Lee, APAC head for medical device firm Avanos explains how the company’s products are catered to patient needs in the region and talks through key growth drivers, the impact…
AstraZeneca (AZ)’s country president for Singapore, Vinod Narayanan, outlines the challenges of taking the reins at an affiliate against the backdrop of a pandemic and how the Anglo-Swedish company’s quest…
One of the main supporting pillars of Singapore’s pharmaceutical industry is its magnificent manufacturing base. Not only does the city-state rank as one of the few countries on the planet…
Cindy Engelbart, director of mid-sized logistics player Agility’s life science operations in APAC, highlights some of the key trends in global logistics that have emerged from the COVID-19 pandemic, how…
In 2020, the FDA granted its first approval to a comprehensive liquid biopsy, potentially representing a paradigm shift towards using liquid biopsies upfront as an easier, safer, faster, and more…
See our Cookie Privacy Policy Here